Liver disease, aminoglycoside antibiotics and renal dysfunction.

Abstract

HepatologyVolume 8, Issue 4 p. 966-968 EditorialFree Access Liver disease, aminoglycoside antibiotics and renal dysfunction Paul S. Lietman M.D., Ph.D., Corresponding Author Paul S. Lietman M.D., Ph.D. The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205Osler 527, Johns Hopkins Hospital, Baltimore, Maryland 21205===Search for more papers by this author Paul S. Lietman M.D., Ph.D., Corresponding Author Paul S. Lietman M.D., Ph.D. The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205Osler 527, Johns Hopkins Hospital, Baltimore, Maryland 21205===Search for more papers by this author First published: July/August 1988 https://doi.org/10.1002/hep.1840080442Citations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Camps J, Sola X, Rimola A. et al. Comparative study of aminogly-coside nephrotoxicity in normal rats and rats with experimental cirrhosis. Hepatology 1988; 8: 837– 844. 2 Moore RD, Smith CR, Lipsky JJ. et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352– 357. 3 Moore RD, Smith CR, Lietman PS. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 1986; 80: 1093– 1097. 4 Smith CR, Moore RD, Lietman PS. Studies of risk factors for aminoglycoside nephrotoxicity. Am J Kidney Dis 1986; 8: 308– 313. 5 Sawyers CL, Moore RD, Lerner SA. et al. A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis 1986; 153: 1062– 1068. 6 Wade JC, Smith CR, Petty BG. et al. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet 1978; 2: 604– 606. 7 Smith CR, Lipsky JJ, Laskin OL. et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980; 302: 1106– 1109. 8 Moore RD, Smith CR, Lietman PS. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 1984; 149: 23– 30. 9 Cabrera J, Arroyo V, Ballesta AM. et al. Aminoglycoside nephrotoxicity in cirrhosis. Gastroenterology 1982; 82: 97– 105. 10 Felisart J, Rimola A, Arroyo V. et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985; 5: 457– 462. 11 Vree TB, Zweens K, Huige PJ, et al. Interaction between the renal excretion rates of beta 2-microglobulin and tobramycin in man. Clin Chim Acta 1984; 138: 49– 57. 12 Smith CR, Lietman PS. Enzymuria and controlled trials of aminoglycosides in healthy human volunteers. In: K Solez, A Whelton, eds. Acute renal failure: correlations between morphology and function. New York: Marcel Dekker, Inc., 1984: 273– 279. 13 Luft FC, Aronoff GR, Evan AP. et al. The effect of aminoglycosides on glomerular endothelium: a comparative study. Res Commun Chem Pathol Pharmacol 1981; 34: 89– 95. 14 Wood AS, Sawyers CL, Smith CR. et al. The effect of bile duct ligation on gentamicin nephrotoxicity in rats (Abstract). Clin Pharmacol Ther 1986; 39: 236. 15 Wood AS, Smith CR, Sawyers CL. et al. The effect of bile duct ligation on gentamicin nephrotoxicity in rats (Abstract). Clin Pharmacol Ther 1988; 43: 198. 16 Desai TK, Tsang T-K. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med (in press). 17 Lipsky JJ, Lefkowith J, Lietman PS. Cytoplasmic and membrane effects of aminoglycosides: a hypothesis for the mechanism of aminoglycoside toxicity. In: K Solez, A Whelton, eds. Acute renal failure: correlations between morphology and function. New York: Marcel Dekker, Inc., 1984: 261– 271. Citing Literature Volume8, Issue4July/August 1988Pages 966-968 ReferencesRelatedInformation